Prognostic impact of TP53 and PPP2R1A mutations in endometrial cancer

Analysis of RWD reveals survival outcomes for co-mutated endometrial cancer

INDICATION
Endometrial
BIOMARKER
TP53

 

Kaplan-Meier survival curves comparing rwOS in 1L treated EC patients stratified by TP53 and PPP2R1A mutation status. Survival analysis is anchored to 1L treatment initiation date. Median survival times (months)  are specified. Log-Rank test P value is indicated.

 

Related cases

Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract data visualization showing a grid of blue, black, and brown dots in patterns.

TP53 mutations are enriched in HER2-positive biliary tract cancer and drive poor outcomes

2026-07-01
Biliary Tract Cancer
TP53
HER2
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
A data visualization showing multiple statistical distributions using pink and black dot plots.

Prognostic impact of TP53 hotspot mutations across solid tumors

2026-05-26
Pan-Cancer
TP53
Icon with three vertical bars and a circle, resembling a bar graph or LinkedIn logo.Lens Library
Abstract pixel pattern featuring two dark vertical shapes on a light grid.

Leveraging multimodal RWD to characterize intratumor heterogeneity in solid tumors

2025-12-22
Pan-Cancer
TP53